Tobacco-Related Carcinoma Clinical Trial
Official title:
Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff
This clinical trial tests the effects of tobacco cut and nicotine form on the abuse liability in participants who use moist snuff (smokeless tobacco [SLT]). Two features of moist snuff that are key targets of manipulation from the tobacco industry and drivers of its addiction potential are length of tobacco cut (long versus fine) and nicotine form (low versus high levels of nicotine in the free-base form). Finer tobacco cuts and higher levels of free-base nicotine (FBN) result in faster, greater nicotine delivery. Researchers want to gain information on how certain characteristics of moist snuff affect how long people use it, how it delivers nicotine, or how much people like it. This clinical trial may provide justifications for local, state, or federal regulations aimed at reducing the appeal and addictiveness of moist snuff.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: - AIM 1 (Adults Tobacco User Adult Cohort [TUAC]): Exclusive adult smokers who smoked >100 cigarettes or other combustible tobacco products in their lifetime and reported being current, every day, or some days/week smokers at time of enrollment - AIM 1 (TUAC): Exclusive SLT user reporting every day or some days use per week at time of enrollment - AIM 1 (TUAC): Or dual users who met criteria for both aims at time of enrollment who resided in participating Appalachian and urban counties - AIM 1 (Buckeye Teen Health Study [BTHS]): Male youth ages 12-15 in Appalachian and urban regions of Ohio with parental consent and participant assent given - AIM 2: As derived from Aim 1, commercially available SLT products used by TUAC and BTHS participants will be purchased from retailers in nearby Appalachian counties, as composition of SLT products can vary regionally - AIM 3: Adults aged 21 and older who reside in an Ohio Appalachian county and use SLT at least 6x/day for at least 6 months will be considered for this project - Daily use (at least 6 dips/day) of moist snuff for at least 6 months - Age 21 years or older - Reside in an Ohio Appalachian county or surrounding rural area - Willing to complete 5 study visits and provide informed consent study procedures, including abstaining from all tobacco, nicotine, and marijuana for 12 hours before clinic visits - Willing to abstain from nicotine and tobacco products 12-hours before study visit - Ability to read and speak English Exclusion Criteria: - Pregnant, planning to become pregnant, or breastfeeding (will be verified with a urine pregnancy test at the first session visit) - Unstable or significant psychiatric conditions (past and stable conditions will be allowed) - History of cardiac event or distress, including but not limited to uncontrolled high blood pressure, chest pain, and shortness of breath, within the past 3 months - Working with a cessation counselor, using cessation devices such as Chantix or Wellbutrin, or planning to quit within the next 3 months - Severe periodontal or oral lesions |
Country | Name | City | State |
---|---|---|---|
United States | Ohio State University Comprehensive Cancer Center | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Ohio State University Comprehensive Cancer Center | National Institute on Drug Abuse (NIDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Frequencies of flavors used by participants | Will be assessed in adolescent and adult participants (expected N=198). Will be evaluated using descriptive statistics | Up to 2 years | |
Primary | Associations between tobacco cut (fine, long, and pouches) and level of smokeless tobacco (SLT) dependence | Will use chi-square tests to estimate associations between tobacco cut (fine, long, and pouches) and level of SLT dependence. If the expected cell size for more than 20% of cells is < 5, Fisher's exact test will be used. | Up to 2 years | |
Primary | Associations between level of dependence and total nicotine in moist snuff | Descriptive statistics will be calculated and variables will be inspected for out-of-range values. The investigators will merge product characteristics into our cohort study data (e.g., characteristics of Grizzly long cut wintergreen moist snuff will be merged to participants who reported using that style). Next, the investigators will use linear regression to estimate the associations between level of dependence and total nicotine. | Up to 2 years | |
Primary | Associations between level of dependence and pH in moist snuff | Descriptive statistics will be calculated and variables will be inspected for out-of-range values. The investigators will merge product characteristics into our cohort study data (e.g., characteristics of Grizzly long cut wintergreen moist snuff will be merged to participants who reported using that style). Next, the investigators will use linear regression to estimate the associations between level of dependence and pH. | Up to 2 years | |
Primary | Associations between level of dependence and free-base nicotine (FBN) in moist snuff | Descriptive statistics will be calculated and variables will be inspected for out-of-range values. The investigators will merge product characteristics into our cohort study data (e.g., characteristics of Grizzly long cut wintergreen moist snuff will be merged to participants who reported using that style). Next, the investigators will use linear regression to estimate the associations between level of dependence and FBN in moist snuff. | Up to 2 years | |
Primary | Moist snuff tobacco cut on product use | Will be assessed by a randomized 2x2 within-subjects design to test whether variations in cut and level of FBN are associated with product use among Appalachian moist snuff users. Data will be summarized descriptively, overall and stratified by dependence. The investigators will use linear mixed effects models to assess the main effects of cut on moist snuff use duration and amount, self-reported measures, and plasma nicotine delivery (i.e., maximum absorption; total absorption; and speed of absorption). Product interaction terms will be used to evaluate whether effects of moist snuff style on outcome variables are modified by level of SLT dependence. | Up to 2 years | |
Primary | Moist snuff tobacco FBN content on product use | Will be assessed by a randomized 2x2 within-subjects design to test whether variations in cut and level of FBN are associated with product use among Appalachian moist snuff users. Data will be summarized descriptively, overall and stratified by dependence. The investigators will use linear mixed effects models to assess the main effects of FBN content on moist snuff use duration and amount, self-reported measures, and plasma nicotine delivery (i.e., maximum absorption; total absorption; and speed of absorption). Product interaction terms will be used to evaluate whether effects of moist snuff style on outcome variables are modified by level of SLT dependence. | Up to 2 years | |
Primary | Moist snuff tobacco cut on product effects | Will be assessed by a randomized 2x2 within-subjects design to test whether variations in cut and level of FBN are associated with subjective effects among Appalachian moist snuff users. Data will be summarized descriptively, overall and stratified by dependence. The investigators will use linear mixed effects models to assess the main effects of cut on moist snuff use duration and amount, self-reported measures, and plasma nicotine delivery (i.e., maximum absorption; total absorption; and speed of absorption). Product interaction terms will be used to evaluate whether effects of moist snuff style on outcome variables are modified by level of SLT dependence. | Up to 2 years | |
Primary | Moist snuff tobacco FBN content on product effects | Will be assessed by a randomized 2x2 within-subjects design to test whether variations in cut and level of FBN are associated with subjective effects among Appalachian moist snuff users. Data will be summarized descriptively, overall and stratified by dependence. The investigators will use linear mixed effects models to assess the main effects of FBN content on moist snuff use duration and amount, self-reported measures, and plasma nicotine delivery (i.e., maximum absorption; total absorption; and speed of absorption). Product interaction terms will be used to evaluate whether effects of moist snuff style on outcome variables are modified by level of SLT dependence. | Up to 2 years | |
Primary | Moist snuff tobacco cut on product appeal | Will be assessed by a randomized 2x2 within-subjects design to test whether variations in cut and level of FBN are associated with product use, nicotine delivery, and subjective effects among Appalachian moist snuff users. Data will be summarized descriptively, overall and stratified by dependence. The investigators will use linear mixed effects models to assess the main effects of cut on moist snuff use duration and amount, self-reported measures, and plasma nicotine delivery (i.e., maximum absorption; total absorption; and speed of absorption). Product interaction terms will be used to evaluate whether effects of moist snuff style on outcome variables are modified by level of SLT dependence. | Up to 2 years | |
Primary | Moist snuff tobacco FBN content on product appeal | Will be assessed by a randomized 2x2 within-subjects design to test whether variations in cut and level of FBN are associated with product use, nicotine delivery, and subjective effects among Appalachian moist snuff users. Data will be summarized descriptively, overall and stratified by dependence. The investigators will use linear mixed effects models to assess the main effects of FBN content on moist snuff use duration and amount, self-reported measures, and plasma nicotine delivery (i.e., maximum absorption; total absorption; and speed of absorption). Product interaction terms will be used to evaluate whether effects of moist snuff style on outcome variables are modified by level of SLT dependence. | Up to 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06315881 -
Informing Oral Nicotine Pouch Regulations to Promote Public Health
|
Phase 2 | |
Active, not recruiting |
NCT02964182 -
Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers
|
N/A | |
Completed |
NCT04267874 -
Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study
|
Early Phase 1 | |
Completed |
NCT04510077 -
SmartQuit Program for Smoking Cessation
|
N/A | |
Completed |
NCT03200236 -
The Lung Screening, Tobacco and Health Project
|
Phase 3 | |
Recruiting |
NCT06448351 -
Manipulating E-Cigarette Nicotine to Promote Public Health
|
N/A | |
Recruiting |
NCT05730439 -
Examining the Impact of Nicotine Pouches in Rural Ohio and Ohio Appalachia
|
Early Phase 1 | |
Recruiting |
NCT04949464 -
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
|
N/A | |
Enrolling by invitation |
NCT04969978 -
Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation
|
N/A | |
Completed |
NCT05972941 -
Nicotine and Tobacco Message Framing Among LGBT Young Adults
|
N/A | |
Completed |
NCT05453773 -
Hookah Additive Research to Inform Product Standards
|
N/A | |
Withdrawn |
NCT05411107 -
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
|
Phase 2 | |
Completed |
NCT03268993 -
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
|
N/A | |
Recruiting |
NCT04340531 -
Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities
|
Phase 4 | |
Terminated |
NCT04297332 -
Episodic Future Thinking and Future Thinking Priming for Smoking Cessation
|
N/A | |
Completed |
NCT03402230 -
Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers
|
Early Phase 1 | |
Recruiting |
NCT05876091 -
Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography
|
N/A | |
Completed |
NCT03182959 -
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
|
Early Phase 1 | |
Completed |
NCT05393869 -
Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults
|
N/A | |
Recruiting |
NCT05679349 -
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
|
N/A |